The US Department of Defense said it will terminate a plan to use Oracle, ORCL, software to manage its civilian workforce as part of the Pentagon’s cost-cutting efforts

The Pentagon has officially shut down a major human resources tech overhaul, and it’s a serious blow to Oracle (NYSE: ORCL) and Leidos (NYSE: LDOS). What began as a $75 million effort to modernize the system for managing 900,000 civilian employees turned into a six-year debacle, ballooning to $280 million over budget. Defense Secretary Pete Hegseth didn’t mince words, calling further investment in the project a “waste of money.” While Oracle’s involvement was never publicly acknowledged, contract records confirmed its role.

The Department of Defense now has 60 days to regroup and draft a new modernization strategy.

Warning! GuruFocus has identified 5 warning signs for ORCL.

Investors reacted swiftly. Oracle shares fell 2%, while Leidos dipped 0.7% as of 10 a.m. today. Both companies declined to comment on the decision.

The cancellation comes as part of broader federal budget tightening under President Trump’s government efficiency push, now overseen by a new White House department led by Elon Musk. The shake-up has put federal software contractors on edge, especially those reliant on long-term government deals. Oracle’s behind-the-scenes exposure in this failed program serves as a stark reminder of the risks tied to such contracts.

Oracle has long been a major player in the federal tech space, previously landing deals like the $16 billion upgrade to the Department of Veterans Affairs health records system. But with cost-cutting now a top priority—and Musk increasingly influencing both tech and budget policy inside the administration—even politically connected firms are finding themselves vulnerable.

The takeaway for investors: government tech spending is entering a new era, and the fallout from this cancellation could signal bigger changes ahead for federal contractors.

4o

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.